Protection of COVID-19 vaccination and previous infection against Omicron BA.1, BA.2 and Delta SARS-CoV-2 infections
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2041-1723
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Protection of COVID-19 vaccination and previous infection against Omicron BA.1, BA.2 and Delta SARS-CoV-2 infections ; volume:13 ; number:1 ; day:12 ; month:8 ; year:2022 ; pages:1-9 ; date:12.2022
Nature Communications ; 13, Heft 1 (12.8.2022), 1-9, 12.2022
- Urheber
-
Andeweg, Stijn P.
Gier, Brechje de
Eggink, Dirk
Ende, Caroline van den
Maarseveen, Noortje van
Ali, Lubna
Vlaemynck, Boris
Schepers, Raf
Hahné, Susan J. M.
Reusken, Chantal B. E. M.
Melker, Hester E. de
Hof, Susan van den
Knol, Mirjam J.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41467-022-31838-8
- URN
-
urn:nbn:de:101:1-2022112709280988674968
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:27 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Andeweg, Stijn P.
- Gier, Brechje de
- Eggink, Dirk
- Ende, Caroline van den
- Maarseveen, Noortje van
- Ali, Lubna
- Vlaemynck, Boris
- Schepers, Raf
- Hahné, Susan J. M.
- Reusken, Chantal B. E. M.
- Melker, Hester E. de
- Hof, Susan van den
- Knol, Mirjam J.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Omicron BA.1 neutralizing antibody response following Delta breakthrough infection compared with booster vaccination of BNT162b2
Delta or Omicron BA.1/2-neutralizing antibody levels and T-cell reactivity after triple-vaccination or infection
BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variants
Bivalent COVID-19 mRNA booster vaccination (BA.1 or BA.4/BA.5) increases neutralization of matched Omicron variants
Omicron BA.4/BA.5 escape neutralizing immunity elicited by BA.1 infection
Disease profile and plasma neutralizing activity of post-vaccination Omicron BA.1 infection in Tianjin, China: a retrospective study
High SARS-CoV-2 incidence and asymptomatic fraction during Delta and Omicron BA.1 waves in The Gambia
In vitro and in vivo differences in neurovirulence between D614G, Delta And Omicron BA.1 SARS-CoV-2 variants
Compensatory epistasis maintains ACE2 affinity in SARS-CoV-2 Omicron BA.1
Author Correction: Omicron BA.4/BA.5 escape neutralizing immunity elicited by BA.1 infection
Clinical severity of SARS-CoV-2 Omicron BA.4 and BA.5 lineages compared to BA.1 and Delta in South Africa
Comparative neutralization profiles of naive and breakthrough infections with Delta, Omicron BA.1 and BA.2 variants of SARS-CoV-2
Omicron BA.1 neutralizing antibody response following Delta breakthrough infection compared with booster vaccination of BNT162b2
Delta or Omicron BA.1/2-neutralizing antibody levels and T-cell reactivity after triple-vaccination or infection
BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variants
Bivalent COVID-19 mRNA booster vaccination (BA.1 or BA.4/BA.5) increases neutralization of matched Omicron variants
Omicron BA.4/BA.5 escape neutralizing immunity elicited by BA.1 infection
Disease profile and plasma neutralizing activity of post-vaccination Omicron BA.1 infection in Tianjin, China: a retrospective study
High SARS-CoV-2 incidence and asymptomatic fraction during Delta and Omicron BA.1 waves in The Gambia
In vitro and in vivo differences in neurovirulence between D614G, Delta And Omicron BA.1 SARS-CoV-2 variants
Compensatory epistasis maintains ACE2 affinity in SARS-CoV-2 Omicron BA.1
Author Correction: Omicron BA.4/BA.5 escape neutralizing immunity elicited by BA.1 infection
Clinical severity of SARS-CoV-2 Omicron BA.4 and BA.5 lineages compared to BA.1 and Delta in South Africa
Comparative neutralization profiles of naive and breakthrough infections with Delta, Omicron BA.1 and BA.2 variants of SARS-CoV-2
Omicron BA.1 neutralizing antibody response following Delta breakthrough infection compared with booster vaccination of BNT162b2
Delta or Omicron BA.1/2-neutralizing antibody levels and T-cell reactivity after triple-vaccination or infection
BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variants
Bivalent COVID-19 mRNA booster vaccination (BA.1 or BA.4/BA.5) increases neutralization of matched Omicron variants
Omicron BA.4/BA.5 escape neutralizing immunity elicited by BA.1 infection
Disease profile and plasma neutralizing activity of post-vaccination Omicron BA.1 infection in Tianjin, China: a retrospective study
High SARS-CoV-2 incidence and asymptomatic fraction during Delta and Omicron BA.1 waves in The Gambia
In vitro and in vivo differences in neurovirulence between D614G, Delta And Omicron BA.1 SARS-CoV-2 variants
Compensatory epistasis maintains ACE2 affinity in SARS-CoV-2 Omicron BA.1
Author Correction: Omicron BA.4/BA.5 escape neutralizing immunity elicited by BA.1 infection
Clinical severity of SARS-CoV-2 Omicron BA.4 and BA.5 lineages compared to BA.1 and Delta in South Africa